Smartphone app enhances retention and reduces opioid use in patients

Patients with opioid use disorder can reduce their days of opioid use and stay in treatment longer when using a smartphone app as supportive therapy in combination with medication, a new study by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) shows.

AI assistance in radiology shows mixed results for performance

One of the most touted promises of medical artificial intelligence tools is their ability to augment human clinicians’ performance by helping them interpret images such

March 20, 2024

Madrigal plans to solidify Rezdiffra’s position in MASH despite start being slower than expected

In March 2024, Madrigal Pharmaceuticals had a breakthrough moment when, after years of research and anticipation, the US Food and Drug Administration (FDA) granted approval

August 13, 2024

Meta Title: Merus NV Patent Filing for CLEC12A Positive Cancer Treatment

According to GlobalData’s company profile on Merus, Personalized cancer vaccines was a key innovation area identified from patents. Merus‘s grant share as of January 2024

April 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.